Verastem, Inc.
Clinical trials sponsored by Verastem, Inc., explained in plain language.
-
New pill targets 'Undruggable' cancer mutation in major trial
Disease control Recruiting nowThis early-stage study is testing a new oral drug called VS-7375, which is designed to block a specific cancer-driving mutation known as KRAS G12D. Researchers will give the drug alone and in combination with other cancer therapies to adults with advanced solid tumors, including …
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Two-Drug combo trial offers hope for women with recurrent ovarian cancer
Disease control Recruiting nowThis study is testing whether a new combination of two oral drugs (avutometinib and defactinib) works better than current standard treatments for women whose low-grade serous ovarian cancer has returned after prior therapy. The trial will involve about 270 participants worldwide …
Phase: PHASE3 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC